直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • News
  • Finnegan Facts
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • Pro Bono
  • Management
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Media Mention

Boston Sci. Accuses 9 Cos. of Infringing Patents

September 28, 2010

Law360

Boston Scientific Corp. is taking nine U.S., Irish, and South Korean companies to task for infringing patents that cover stents and delivery services for treating digestive diseases. The medical device manufacturer filed a complaint Monday in the U.S. District Court for the District of Massachusetts, contending it has suffered damages because of endoscopy products that those companies have made, imported, or sold that bear a close resemblance to its own line of such devices, including the WallFlex stent. The suit accuses Cook, Inc., Wilson-Cook Medical Inc., Cook Medical Inc., Cook Ireland Ltd., Cook Group Inc., Standard Sci-Tech Inc, EndoChoice Inc., Sewoon Medical Co., Ltd. and Taewoong Medical Co. Ltd. of infringing U.S. Patent No. 6,007,574, titled “Stent,” U.S. Patent No. 6,533,810, titled “Conical Stent,” and U.S. Patent No. 6,818,015, also titled “Conical Stent.” Those patents are either owned or licensed to Boston Scientific or its subsidiaries, according to the complaint and Boston Scientific is seeking a judgment that the patents have been infringed as well as unspecified damages. Boston Scientific is represented by Finnegan.

Related News

Award/Ranking

Finnegan Recognized Again Among Germany’s Leading Law Firms

October 9, 2026

Press Release

Finnegan Secures Summary Determination of No Violation in ITC Vehicle Space Guards Investigation for Drop Stop

October 6, 2026

Award/Ranking

Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027

September 24, 2026

Award/Ranking

Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026

September 23, 2026

Press Release

Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower

September 23, 2026

Commentary

New Thomas Pink Womenswear Lines Strain ‘Pink’ Pact with Victoria’s Secret

September 21, 2026

Commentary

FORUM IP Talks: Dr. Jochen Herr on UPC, FRAND, and Cross-Border Enforcement Topics

September 20, 2026

Commentary

Pepsi's U.S. Trademark Dispute Could Reshape Brand Choices, Lawsuit Strategy, Lawyers Say

September 17, 2026

Commentary

Jellycat’s ‘Dupe’ Dilemma: Can IP Protect a ‘Cute’ Aesthetic?

September 16, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP